[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4149 Introduced in House (IH)]







106th CONGRESS
  2d Session
                                H. R. 4149

To amend title XVIII of the Social Security Act to preserve coverage of 
      drugs and biologicals under part B of the Medicare Program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 3, 2000

 Mr. Bilirakis (for himself, Mr. Shaw, Mr. Bliley, Mr. Greenwood, Mr. 
    Lazio, Mr. Burr of North Carolina, Mr. Bryant, Mrs. Johnson of 
 Connecticut, and Mr. Towns) introduced the following bill; which was 
referred to the Committee on Commerce, and in addition to the Committee 
 on Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to preserve coverage of 
      drugs and biologicals under part B of the Medicare Program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medicare Drug Coverage Preservation 
Act of 2000''.

SEC. 2. PRESERVATION OF COVERAGE OF DRUGS AND BIOLOGICALS UNDER PART B 
              OF THE MEDICARE PROGRAM.

    (a) In General.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)) is amended, in each of subparagraphs (A) and (B), 
by striking ``(including drugs and biologicals which cannot, as 
determined in accordance with regulations, be self-administered)'' and 
inserting ``(including drugs and biologicals which are not usually 
self-administered by the patient)''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to drugs and biologicals administered on or after October 1, 2000.
                                 <all>